Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers

Objective: This study aimed to demonstrate the diagnostic value of microarray testing in autism spectrum disorder, intellectual disability, and multiple congenital anomalies of unknown etiology, as well as to report some potential candidate genes for autism. Methods: Microarray analysis records betw...

Full description

Saved in:
Bibliographic Details
Main Authors: Akif AYAZ, Alper GEZDIRICI, Elif YILMAZ GULEC, Özge OZALP, Abdullah Huseyin KOSEOGLU, Zeynep DOGRU, Sinem YALCINTEPE
Format: Article
Language:English
Published: Galenos Publishing House 2022-06-01
Series:Medeniyet Medical Journal
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-70962
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581951970607104
author Akif AYAZ
Alper GEZDIRICI
Elif YILMAZ GULEC
Özge OZALP
Abdullah Huseyin KOSEOGLU
Zeynep DOGRU
Sinem YALCINTEPE
author_facet Akif AYAZ
Alper GEZDIRICI
Elif YILMAZ GULEC
Özge OZALP
Abdullah Huseyin KOSEOGLU
Zeynep DOGRU
Sinem YALCINTEPE
author_sort Akif AYAZ
collection DOAJ
description Objective: This study aimed to demonstrate the diagnostic value of microarray testing in autism spectrum disorder, intellectual disability, and multiple congenital anomalies of unknown etiology, as well as to report some potential candidate genes for autism. Methods: Microarray analysis records between January 2016 and December 2017 from two Genetic Diagnostic Centers in Turkey, Kanuni Sultan Suleyman and Adana Numune Training and Research Hospital, were compiled. Detected copy number variations (CNVs) were classified as benign, likely benign, variants of uncertain significance (VUS), likely pathogenic, and pathogenic according to American College of Medical Genetics and Genomics guidelines. The clinical findings of the some patients and the literature data were compared. Results: In 109 (24.5%) of 445 patients, a total of 163 CNVs with reporting criterion feature were detected. Sixty-nine (42%) and 8 (5%) of these were evaluated as pathogenic and likely pathogenic, respectively. Fifteen (9%) CNVs were also evaluated as VUS. Pathogenic or likely pathogenic CNVs were detected in 61 (13.6%) of 445 patients. Conclusions: We found that the probability of elucidating the etiology of microarray method in autism spectrum disorder, intellectual disability, and multiple congenital anomalies is 13.6% with a percentage similar to the literature. We suggest that the MYT1L, PXDN, TPO, and AUTS2 genes are all strong candidate genes for autism spectrum disorders. We detailed the clinical findings of the cases and reported that some CNV regions in the genome may be associated with autism.
format Article
id doaj-art-51c0e2c9131d4c03b2118965ee1a54e9
institution Kabale University
issn 2149-2042
2149-4606
language English
publishDate 2022-06-01
publisher Galenos Publishing House
record_format Article
series Medeniyet Medical Journal
spelling doaj-art-51c0e2c9131d4c03b2118965ee1a54e92025-01-30T07:13:14ZengGalenos Publishing HouseMedeniyet Medical Journal2149-20422149-46062022-06-0137218019310.4274/MMJ.galenos.2022.70962MEDJ-70962Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two CentersAkif AYAZ0Alper GEZDIRICI1Elif YILMAZ GULEC2Özge OZALP3Abdullah Huseyin KOSEOGLU4Zeynep DOGRU5Sinem YALCINTEPE6Istanbul Medipol University Faculty of Medicine, Department of Medical Genetics, Istanbul, TurkeyUniversity of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Genetic Diseases Assessment Center, Istanbul, TurkeyIstanbul Medeniyet University Faculty of Medicine, Department of Medical Genetics, Istanbul, TurkeyUniversity of Health Sciences Turkey, Adana City Training and Research Hospital, Genetic Diseases Assessment Center, Adana, TurkeyIstanbul Medipol University, Genetic Diseases Assessment Center, Istanbul, TurkeyIstanbul Medipol University, Genetic Diseases Assessment Center, Istanbul, TurkeyTrakya University Faculty of Medicine, Department of Medical Genetics, Edirne, TurkeyObjective: This study aimed to demonstrate the diagnostic value of microarray testing in autism spectrum disorder, intellectual disability, and multiple congenital anomalies of unknown etiology, as well as to report some potential candidate genes for autism. Methods: Microarray analysis records between January 2016 and December 2017 from two Genetic Diagnostic Centers in Turkey, Kanuni Sultan Suleyman and Adana Numune Training and Research Hospital, were compiled. Detected copy number variations (CNVs) were classified as benign, likely benign, variants of uncertain significance (VUS), likely pathogenic, and pathogenic according to American College of Medical Genetics and Genomics guidelines. The clinical findings of the some patients and the literature data were compared. Results: In 109 (24.5%) of 445 patients, a total of 163 CNVs with reporting criterion feature were detected. Sixty-nine (42%) and 8 (5%) of these were evaluated as pathogenic and likely pathogenic, respectively. Fifteen (9%) CNVs were also evaluated as VUS. Pathogenic or likely pathogenic CNVs were detected in 61 (13.6%) of 445 patients. Conclusions: We found that the probability of elucidating the etiology of microarray method in autism spectrum disorder, intellectual disability, and multiple congenital anomalies is 13.6% with a percentage similar to the literature. We suggest that the MYT1L, PXDN, TPO, and AUTS2 genes are all strong candidate genes for autism spectrum disorders. We detailed the clinical findings of the cases and reported that some CNV regions in the genome may be associated with autism.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-70962microarrayautism spectrum disordersautism genes and cnv regions
spellingShingle Akif AYAZ
Alper GEZDIRICI
Elif YILMAZ GULEC
Özge OZALP
Abdullah Huseyin KOSEOGLU
Zeynep DOGRU
Sinem YALCINTEPE
Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
Medeniyet Medical Journal
microarray
autism spectrum disorders
autism genes and cnv regions
title Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
title_full Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
title_fullStr Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
title_full_unstemmed Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
title_short Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
title_sort diagnostic value of microarray method in autism spectrum disorder intellectual disability and multiple congenital anomalies and some candidate genes for autism experience of two centers
topic microarray
autism spectrum disorders
autism genes and cnv regions
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-70962
work_keys_str_mv AT akifayaz diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT alpergezdirici diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT elifyilmazgulec diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT ozgeozalp diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT abdullahhuseyinkoseoglu diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT zeynepdogru diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters
AT sinemyalcintepe diagnosticvalueofmicroarraymethodinautismspectrumdisorderintellectualdisabilityandmultiplecongenitalanomaliesandsomecandidategenesforautismexperienceoftwocenters